期刊文献+

降浊解毒汤治疗甲状腺功能亢进症100例临床观察 被引量:6

Clinical effect of Jiangzhuo Jiedu decoction in treatment of hyperthyroidism:An analysis of 100 cases
原文传递
导出
摘要 目的:观察降浊解毒汤治疗痰浊瘀毒型甲状腺功能亢进症的临床疗效。方法:将100例痰浊瘀毒型甲状腺功能亢进症患者随机分为治疗组与对照组各50例。对照组采用甲巯咪唑治疗,治疗组在对照组治疗基础上加用降浊解毒汤治疗。结果:总有效率治疗组为90.0%,对照组为86.0%,2组比较,差异有统计学意义(P<0.05);2组TGAb、TPOAb水平治疗前后组内比较及治疗后组间比较,差异均有统计学意义(P<0.05)。结论:降浊解毒汤治疗痰浊瘀毒型甲状腺功能亢进症有较好的临床疗效。 Objective: To investigate the clinical effect of Jiangzhuo Jiedu decoction in the treatment of hyperthyroidism with turbid phlegm and stasis toxin. Methods: A total of 100 patients with hyperthyroidism with turbid phlegm and stasis-toxin were randomly divided into treatment group and control group,with 50 patients in each group. The patients in the control group were given methimazole,and those in the treatment group were given Jiangzhuo Jiedu decoction in addition to the treatment in the control group. Results: There was a significant difference in overall response rate between the treatment group and the control group( 90. 0% vs 86. 0%,P〈 0. 05). Both groups had significant reductions in the levels of TGAb and TPOAb after treatment,and there were significant differences between the two groups after treatment( P〈 0. 05). Conclusion: Jiangzhuo Jiedu decoction has a good clinical effect in the treatment of hyperthyroidism with turbid phlegm and stasis-toxin.
作者 温小凤 杨紫皓 彭瑶 解发良 WEN Xiao - feng1 , YANG Zi - hao2 , PENG Yao3 , XIE Fa - liang1(1. The Affiliated Hospital of Hunan Academy of Chinese Medicine, Changsha 410006, Hunan, China ; 2. Hunan University of Chinese Medicine, Changsha 410208, Hunan, China ; 3. Pingxiang Health School, Pingxiang 337000, Jiangxi, Chin)
出处 《湖南中医杂志》 2018年第8期4-6,共3页 Hunan Journal of Traditional Chinese Medicine
基金 湖南省中医药科研计划项目(编号:2015105)
关键词 甲状腺功能亢进症 痰浊瘀毒型 中医药疗法 降浊解毒汤 hyperthyroidism turbid phlegm and stasis- toxin traditional Chinese medicine treatment Jiangzhuo Jiedu decoction
  • 相关文献

参考文献1

二级参考文献60

  • 1阎胜利.Graves病与环境因素[J].山东医药,2005,45(7):63-64. 被引量:3
  • 2Brix TH,Hansen PS,Kyvik KO,et al.Cigarette smoking and risk of clinically overt thyroid disease:a population-based twin case-control study[J].Arch Intem Med,2000,160(5):661-666.
  • 3Vestergaard P,Rejnmark L,Weeke J,et al.Smoking as a risk factor for Graves'disease,toxic nodular goiter,and autoimmune hypothyroidism[J].Thyroid,2002,12(1):69-75.
  • 4Holm IA,Manson JE,Michels KB,et al.Smoking and other lifestyle factors and the risk of Graves'hyperthy-roidism[J].Arch Intern Med,2005,165(14):1606-1611.
  • 5Vestergaard P.Smoking and thyroid disorders--a meta-analysis[J].Eur J Endocrinol,2002,146(2):153-161.
  • 6Steinmaus C,Miller MD,Howd R.Impact of smoking and thiocyanate on perchlorate and thyroid hormone asso-ciations in the 2001-2002 national health and nutrition examination survey[J].Environ Health Perspect,2007,115(9):1333-1338.
  • 7Phenekos C,Vryonidou A,Gritzapis AD,et al.Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1)and Graves'disease (Th2)[J].Neuroimmunomodulation,2004,11(4):209-213.
  • 8Kita-Furuyama M,Nagayama Y,Piehurin P,et al.Dendritic cells infected with adenovirus expressing the thyrotmphin receptor induce Graves'hyperthyroidism in BALB/c mice[J].Clin Exp Immunol,2003,131(2):234-240.
  • 9Weetman AP.Graves'disease[J].N Engl J Med,2000,343(17):1236-1248.
  • 10Villanueva R,Greenberg DA,Davies TF,et al.Sibling recurrence risk in autoimmune thyroid disease[J].Thyroid,2003,13(8):761-764.

共引文献12

同被引文献81

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部